| Bryan T Turnbow, RPH | |
|
1301 10th St, Alamogordo, NM 88310-5804 | |
| (505) 437-5530 | |
| Not Available |
| Full Name | Bryan T Turnbow |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1301 10th St, Alamogordo, New Mexico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275749103 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 6208 (New Mexico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Bryan T Turnbow, RPH 3422 Chimney Rock Rd, Las Cruces, NM 88011-3601 Ph: (505) 521-7001 | Bryan T Turnbow, RPH 1301 10th St, Alamogordo, NM 88310-5804 Ph: (505) 437-5530 |
News Archive
Losing a limb can be a traumatic experience and, in some cases, emotional and physical pain can linger for years. To better understand the phenomenon, dubbed "phantom limb syndrome," Université de Montreal graduate student Emma Duerden is inviting amputees to come forward and share their experiences for a major study.
Rui Costa, principal investigator of the Champalimaud Neuroscience Programme at the Instituto Gulbenkian de Ciencia (IGC), in Portugal, is one of only 219 recipients of the prestigious European Research Council Starting grants, out of 2503 applicants for the 2009 edition of this flagship award scheme. The grant, totalling close to 1.6 million euro, for a period of five years, will allow Rui Costa's young research team to pursue their research into the neurological mechanisms underlying goal-directed decision making behaviour, versus habit-based responses.
Clinical trial data indicated an association between the anti-inflammatory medication rofecoxib and cardiovascular risk as early as December 2000, before the product was taken off the market in September 2004, according to a report in the November 23 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today reported dosing of the first patient in the second of three planned Phase 3 studies that will form the basis of a planned New Drug Application for the Sufentanil NanoTab PCA System, ARX-01.
› Verified 6 days ago
Priscilla Reynolds, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 955 N White Sands Blvd, Alamogordo, NM 88310 Phone: 575-434-4116 Fax: 575-434-4116 | |
Kimberley Peter, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2669 Scenic Dr, Gerald Champion Regional Medical Center, Pharmacy Dept., Alamogordo, NM 88310 Phone: 575-443-7979 | |
Hal W Sims, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1301 10th St, Alamogordo, NM 88310 Phone: 505-437-5530 | |
Dr. Efren Miranda Iii, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3201 N White Sands Blvd, Alamogordo, NM 88310 Phone: 575-434-1324 | |
Megan Harrington, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2669 Scenic Dr, Alamogordo, NM 88310 Phone: 575-443-7984 | |
Wei Quan Leong, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 955 N White Sands Blvd, Alamogordo, NM 88310 Phone: 575-434-4116 Fax: 575-434-4579 | |
Dr. Nadia Alexandra Renteria, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 26 Pueblo Del Sol, Alamogordo, NM 88310 Phone: 575-491-2718 |